| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |